D

DEKA Research & Development Corp.

Independent R&D lab developing medical devices

Electrical Engineer Co-op

Spring 2027
No salary listed
Internship
Manchester, NH, USA
In PersonShort-term housing in Manchester is limited; housing assistance is not available.
Hardware EngineeringHardware Validation & Testing, Board & Electronics Design

About the job

Requirements
  • Must be currently enrolled in an undergraduate Electrical Engineering program as a junior or senior, or in a graduate Electrical Engineering program.
  • Must be at least 18 years of age.
  • Must have demonstrated hands-on experience through technical academic or personal projects.
  • Must have knowledge of analog circuits, including signal and low-power circuits.
  • Must have knowledge of digital electronics.
  • Must have exposure to electrical computer-aided design tools for schematic and layout.
  • Must have excellent verbal and written communication skills.
  • Must be a self-starter eager to contribute in a team environment.
  • Must be detail oriented.
  • Must be a full-time student, defined as enrolled in at least 12 credits per semester in an undergraduate program or at least 9 credits per semester in a graduate program.
Responsibilities
  • Support development of new products and new product concepts.
  • Perform characterization of electrical circuits and document performance.
  • Assist in failure analysis.
  • Perform verification and validation activities using test equipment and test fixtures.
  • Troubleshoot electromechanical prototypes.
  • Operate software on embedded systems.
  • Use electrical computer-aided design tools for schematic and layout, including Altium.
  • Use electrical engineering knowledge and principles to solve problems.
Desired Qualifications
  • Medical-device-related experience is a plus.

About the company

D

DEKA Research & Development Corp.

View

DEKA Research & Development Corp. is a leading engineering R&D lab in Manchester, New Hampshire that develops a wide range of practical technologies and devices. It operates by interdisciplinary teams of engineers, machinists, designers, and technicians who take ambitious ideas and turn them into tangible products using advanced design and manufacturing methods. The company differentiates itself through its culture of hands-on experimentation, diverse project portfolio, and a track record of bringing to market or translating ideas into real-world applications. Its goal is to create technologies with a positive, lasting impact on people’s lives by solving meaningful problems.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Manchester, New Hampshire

Founded

1982

Get referred to DEKA Research & Development Corp.

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Diatech acquisition on October 7, 2025 deepened DEKA’s diabetes delivery stack.
  • Emergex collaboration keeps DEKA’s intradermal applicator active across 2026 biotech pipelines.
  • Revelio counted 872 employees in March 2026, and hiring stayed active.

What critics are saying

  • Sequel Med Tech drives twiist commercialization; any 2026 launch miss starves DEKA royalties.
  • Dean Kamen’s February 2026 Epstein scrutiny pressures recruiting, partnerships, and nonprofit ties.
  • DEKA’s revenue depends on a narrow medical-device portfolio; one regulatory failure hurts everything.

What makes DEKA Research & Development Corp. unique

  • Dean Kamen’s 1982 engineering bench produced LUKE, iBOT, and twiist.
  • DEKA owns core infusion and microneedle IP, not just outsourced design.
  • FDA cleared twiist in 2025, proving repeatable regulated-device execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options

Company News

Emergex Vaccines Holding Limited
Jan 16th, 2024
Emergex Announces R&D Collaboration with DEKA Research & Development Corp. for Assessment of Emergex's Immunotherapeutic Candidates with DEKA's Intradermal Therapeutic Applicator

- Emergex has entered into an agreement with DEKA Research & Development ('DEKA') to assess the compatibility of Emergex's T cell-priming set-point immunotherapeutic candidates with DEKA's Intradermal Therapeutic Applicator.

Business Wire
Oct 13th, 2022
Revolutionary And Affordable New Robotics System Makes Debut At 2022 First Global Challenge = A Win For Stem Equity

The XRP robot kits can help democratize robotics by getting younger generations excited about STEM and making the field of robotics more affordable and accessible in all parts of the world. The XRP robot kits can help democratize robotics by getting younger generations excited about STEM and making the field of robotics more affordable and accessible in all parts of the world